Thromboxanes in glomerulonephritis: what about therapy?
A detailed consideration of how thromboxanes are implicated in glomerulonephritis is followed by a summary of how they have been used successfully in experimental and clinical situations. Most human studies have been short-term only.
Wardle
E N
EN
D000818:Animals; D002986:Clinical Trials as Topic; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000209:etiology; D011507:Proteinuria / Q000209:etiology; D013931:Thromboxanes / Q000037:antagonists & inhibitors / Q000502:physiology*
D013931:Thromboxanes